Reneo Pharmaceuticals Inc
Biotechnology
Healthcare
RPHM
30.22 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
1.61
52 week high
10.50
high
1.71
52 week low
1.34
low
1.61
growth
-36.15 %
previous Close
1.60
P/E ratio
market cap
219 M
div yield
0
usd
Jun 2023
qoq
revenue
0.00 %
net incoming
-19.53 M
-38.61 %
eps
0.00 %
-8.33 %
eps surprise
-25.00 %
net profit margin
-1953100000.00 %
0.00 %
operating incoming
-21.04 M
-30.49 %
net change in cash
0.00 %
cash on hand
9.08 M
-70.12 %
cost of revenue
0.00 %
top top